Aug 31, 2023 07:30AM
Aug 31, 2023 07:30AM
Aug 30, 2023 04:05PM
Aug 30, 2023 04:05PM
May 1, 2023 08:30AM
May 1, 2023 08:30AM
Mar 27, 2023 04:01PM Acer Therapeutics Reports Q4 and Full Year 2022 Financial Results and Provides Corporate Update
Mar 22, 2023 08:32AM
Mar 22, 2023 08:30AM
Mar 17, 2023 08:31AM
Mar 17, 2023 08:30AM
Mar 15, 2023 08:30AM
Feb 13, 2023 08:30AM
Jan 31, 2023 08:00AM SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Jan 9, 2023 08:37AM
Jan 9, 2023 08:30AM
Jan 5, 2023 08:30AM
Dec 27, 2022 08:32AM
Dec 27, 2022 08:30AM
Dec 23, 2022 02:03PM
Nov 14, 2022 05:08PM Acer Therapeutics Reports Q3 2022 Financial Results and Provides Corporate Update
Oct 26, 2022 08:31AM
Oct 26, 2022 08:30AM
Oct 18, 2022 04:05PM
Oct 6, 2022 08:30AM
Oct 3, 2022 08:33AM
Oct 3, 2022 08:30AM
Aug 15, 2022 04:00PM Acer Therapeutics Reports Q2 2022 Financial Results and Provides Corporate Update
Aug 12, 2022 08:33AM
Aug 12, 2022 08:30AM
Jul 28, 2022 08:33AM
Jul 28, 2022 08:33AM
Jul 28, 2022 08:30AM
Jul 18, 2022 08:31AM
Jul 18, 2022 08:30AM Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs
Jul 8, 2022 08:31AM
Jul 8, 2022 08:30AM
Jun 27, 2022 08:30AM
Jun 21, 2022 08:32AM
Jun 21, 2022 08:30AM
Jun 7, 2022 08:32AM
Jun 7, 2022 08:30AM Acer Therapeutics Issues Statement Regarding PDUFA Target Action Date for ACER-001
May 16, 2022 04:01PM
May 9, 2022 08:32AM
May 9, 2022 08:30AM
May 6, 2022 08:30AM
May 6, 2022 01:40AM
May 5, 2022 08:30AM
Apr 12, 2022 08:30AM Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting
Apr 12, 2022 01:20AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All